Women treated with hormones during menopause do not face a higher risk of dying from cancer or cardiovascular diseases than non-users. This is the...

As dementia and other neurodegenerative diseases become more common worldwide, researchers are searching urgently for ways to protect the brain as we...

THURSDAY, Feb. 12, 2026 -- Initiation of hormone therapy (HT) after age 65 years is tied to significantly increased risks for cancer and vascular...

THURSDAY, Feb. 12, 2026 -- Initiation of hormone therapy (HT) after age 65 years is tied to significantly increased risks for cancer and vascular...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder...

A medication commonly used to treat overactive bladder significantly reduced hot flashes in men receiving hormone therapy for prostate cancer,...

A medication commonly used to treat overactive bladder significantly reduced hot flashes in men receiving hormone therapy for prostate cancer,...

Endometrial cancer incidence continues to rise in many countries, particularly among women with metabolic dysfunction, obesity, and benign uterine...

Endometrial cancer incidence continues to rise in many countries, particularly among women with metabolic dysfunction, obesity, and benign uterine...